In a brief research report, authors from University of Washington report that screening for opioid use disorder (OUD) in a primary care setting did not significantly boost the percentage of new diagnoses. Screening sensitivity could be a contributing factor and the authors suggest that addressing stigma may increase the sensitivity of the screening instrument. The report is published in Annals of Internal Medicine.
Researchers analyzed data from 20 primary care clinics screening 167,710 patients for OUD to compare the percentage of patients who were newly diagnosed with OUD before and after implementation of the universal screening initiative. They found that only 0.11 percent of those screened had a new OUD diagnosis, only 0.03 percentage points more than before universal screening. Initial screening efforts occurred during the COVID-19 pandemic, but the authors note that anecdotal evidence suggests that post-pandemic screening was no more effective. They highlight that these findings may be influenced by multiple factors, including lower true prevalence of OUD, greater stigma (resulting in lower screener sensitivity than has been observed in psychometric studies), and/or greater delays in follow-up diagnostic assessments. The authors suggest that to address OUD in their communities, clinics may want to conduct outreach activities and publicize their commitment to accepting new patients seeking care for OUD.
